Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
Acrivon Therapeutics, Inc. (ACRV) Ownership Overview
44.33% Insiders
2.55% Mutual Funds
34.96% Other Institutional Investors
2.38% ETFs
15.77% Public Companies and Individual Investors
The ownership structure of Acrivon Therapeutics, Inc. (ACRV) stock is a mix of institutional, retail, and individual investors. Approximately 39.90% of the company’s stock is owned by Institutional Investors, 44.33% is owned by Insiders, and 15.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 16, 2026 | xxxxxxxxxxxxx | $81830 | |
Jan 16, 2026 | xxxxxxxxxxxxx | $14926 | |
Jan 15, 2026 | xxxxxxxxxxxxx | $17200 | |
May 01, 2025 | xxxxxxxxxxxxx | $1017919 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,340,508 | Institution | 26.43% | 14,178,864 | |
| 8,340,508 | Insider | 26.43% | 14,178,864 | |
| 5,360,858 | Institution | 16.99% | 9,113,459 | |
| 3,104,139 | Insider | 9.84% | 5,277,036 | |
| 2,394,331 | Insider | 7.59% | 4,070,363 | |
| 706,930 | Institution | 2.24% | 1,201,781 | |
| 567,718 | Institution | 1.80% | 965,121 | |
| 163,470 | Institution | 0.52% | 277,899 | |
| 74,585 | Insider | 0.24% | 126,795 | |
| 45,466 | Institution | 0.14% | 77,292 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 567,718 | Institution | 1.80% | 965,121 | |
| 163,470 | Institution | 0.52% | 277,899 | |
| 38,000 | Institution | 0.12% | 64,600 | |
| 19,157 | Institution | 0.06% | 32,567 | |
| 11,821 | Institution | 0.04% | 20,096 | |
| 4,164 | Institution | 0.01% | 7,079 | |
| 802 | Institution | <0.01% | 1,363 | |
| 468 | Institution | <0.01% | 796 | |
| 167 | Institution | <0.01% | 284 | |
| 74 | Institution | <0.01% | 126 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 545,541 | Institution | 1.73% | 976,518 | |
| 161,389 | Institution | 0.51% | 288,886 | |
| 45,466 | Institution | 0.14% | 73,655 | |
| 4,818 | Institution | 0.02% | 26,692 |
FAQ
Who Owns Acrivon Therapeutics, Inc. (ACRV)?
According to the latest TipRanks data, approximately 34.96% of the company's stock is held by institutional investors, 44.33% is held by insiders, and 15.77% is held by retail investors.
What percentage of Acrivon Therapeutics, Inc. (ACRV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.96% of Acrivon Therapeutics, Inc. (ACRV) stock is held by institutional investors.
What percentage of Acrivon Therapeutics, Inc. (ACRV) stock is held by retail investors?
According to the latest TipRanks data, approximately 15.77% of Acrivon Therapeutics, Inc. (ACRV) stock is held by retail investors.
Who owns the most shares of Acrivon Therapeutics, Inc. (ACRV)?
Peter Kolchinsky owns the most shares of Acrivon Therapeutics, Inc. (ACRV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.